AntiCancer (United States)

957 papers and 32.4k indexed citations i.

About

In recent decades, authors affiliated with AntiCancer (United States) have published 957 papers, which have received a total of 32.4k indexed citations. Scholars at this organization have produced 668 papers in Biotechnology, 373 papers in Biomedical Engineering and 307 papers in Genetics on the topics of Cancer Research and Treatments (664 papers), Nanoplatforms for cancer theranostics (346 papers) and Virus-based gene therapy research (290 papers). Their work is cited by papers focused on Biotechnology (14.0k citations), Molecular Biology (11.0k citations) and Biomedical Engineering (10.6k citations). Authors at AntiCancer (United States) collaborate with scholars in United States, Japan and China and have published in prestigious journals including Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry. Some of AntiCancer (United States)'s most productive authors include Robert M. Hoffman, Michael Bouvet, Meng Yang, Ming Zhao and Shinji Miwa.

In The Last Decade

Fields of papers published by authors at AntiCancer (United States)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with AntiCancer (United States) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at AntiCancer (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at AntiCancer (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at AntiCancer (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AntiCancer (United States) more than expected).

Rankless by CCL
2025